Multiple Myeloma: Stem Cell Transplant and Beyond 2021 Summary: Learn when patients with myeloma should consider transplant, steps involved in transplant, maintenance therapy options after transplant, and new therapies to manage multiple myeloma. Multiple myeloma is the most common cancer of the bone marrow. This presentation discusses transplant options and drug therapies for treating myeloma. […]

What Are The Stages Of Multiple Myeloma? Multiple myeloma is a cancer of plasma cells, which are a typically located in the bone marrow. The bone marrow is the soft, sponge-like tissue in the center of most bones. Dr. Cesar Rodriguez Valdes discusses what you need to know about multiple myeloma, including how it is […]

Screening programs for plasma cell disorders Irene Ghobrial, MD, of the Dana-Farber Cancer Institute, Boston, MA, and Maria-Victoria Mateos, MD, PhD, of the University of Salamanca, Salamanca, Spain, discuss the importance of screening and explain how a screening programme for early stages of myeloma could significantly improve survival outcomes for patients. Dr Ghobrial talks on […]

LESSON 4 – 4 Multiple Myeloma – MM

Managing Multiple Myeloma: How Emerging Therapies Can Help The Leukemia & Lymphoma Society of Canada invites you to learn more about multiple myeloma. Dr. Ismail Sharif will provide an overview of the current and emerging treatment options, and share information on how to manage symptoms and treatment-related side effects.

Multiple Myeloma Abstracts Dealing with Health Disparities Presented at ASH 2021 IMF Chief Medical Officer Dr. Joseph Mikhael Addresses Disparities in Myeloma Care From ASH 2021 _______________ Improving Lives | Finding the Cure In the United States, an estimated 32,270 new multiple myeloma cases will be diagnosed in 2021. 159,985 new myeloma cases are diagnosed […]

Pathology — dr.Nafe'a — Plasma cell tumors (1) — Multiple Myeloma اللهم صل وسلم على سيدنا وحبيبنا وشفيعنا محمد وعلى آله وصحبه أجمعين .. ومن يتق الله يجعل له مخرجاَ .. ويرزقه من حيث لا يحتسب .. احفظ الله يحفظك .. احفظ الله تجده تجاهك .. واجعلوا لنا نصيباَ من دعائكم .. 

Natural Killer Cells as Add-on Therapy for Multiple Myeloma is Showing Promise in the Lab Nina Shah, MD, Hematologist from the University of California, San Francisco, discusses preclinical data demonstrating that a subset of human natural killer (NK) cells that lack expression of FcεRIγ (g-NK cells) enhance the efficacy of monoclonal antibody treatment in multiple […]

Iberdomide + dexamethasone in R/R multiple myeloma Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD, University College London Hospitals, London, UK, presents the results of a study evaluating iberdomide, a cereblon E3 ligase modulator (CELMoD) agent, in combination with dexamethasone in patients with triple-class refractory multiple myeloma or in patients who have been exposed to an […]

Our Ongoing Commitment to Multiple Myeloma Patients Globally, about 176K people were diagnosed with #MultipleMyeloma (MM) in 2021. Despite current treatment options, high relapse rates require innovative approaches. We’re working to evolve research around #BCMA, a promising target in MM. For more: https://www.mmwayforward.com/ #EBMT22